Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1649 1675
This examiner grants 55% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18008324 | ACVR1 (ALK2) RECEPTOR INHIBITION TO TREAT NEUROLOGICAL DISEASES | Non-Final OA | The Regents of the University of California |
| 18177566 | COMPOSITIONS AND METHODS FOR CROSSING BLOOD BRAIN BARRIER | Non-Final OA | California Institute of Technology |
| 17784634 | FUSION POLYPEPTIDE COMPRISING GDF15 AND POLYPEPTIDE REGION CAPABLE OF O-GLYCOSYLATION | Final Rejection | LG CHEM, LTD. |
| 17490409 | FSH LOWERING AGENT OR ACTIVIN PATHWAY MODIFYING AGENT TO TREAT INFERTILITY IN FEMALES | Non-Final OA | University Of Cincinnati |
| 18283665 | ANTIBODY OR FRAGMENT THEREOF, AND METHOD FOR USING SAME | Non-Final OA | NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEM |
| 17628132 | ADHESIVE PROTEIN | Final Rejection | National University Corporation Tokai National Higher Education and Research System |
| 17554713 | Anti-CGRP Antibody Formulation | Non-Final OA | Eli Lilly and Company |
| 18269380 | IMMUNE CHECKPOINTS | Non-Final OA | Vrije Universiteit Brussel |
| 18431041 | Method for Diagnosing and Assessing Endometriosis | Final Rejection | McMaster University |
| 17766112 | METHODS OF DETECTING circRNA | Non-Final OA | Washington University |
| 18767636 | PLACENTAL PROTEIN BIOMARKERS FOR GESTATIONAL AGE ASSESSMENT AND RELATED METHODS | Non-Final OA | Gynuity Health Projects, Inc. |
| 17627953 | MUCIN ISOFORMS IN DISEASES CHARACTERIZED BY BARRIER DYSFUNCTION | Non-Final OA | Universiteit Antwerpen |
| 18296763 | ADM2 GENE MARKER FOR DIAGNOSIS OR PROGNOSIS PREDICTION OF THYROID CANCER AND USES THEREOF | Non-Final OA | The Industry & Academic Cooperation in Chungnam National University (IAC) |
| 17909036 | METHOD FOR QUANTIFYING ADIPONECTIN AND ANALYTICAL REAGENT USED THEREOF | Final Rejection | Tatsuya SAWAMURA |
| 18346961 | ANTI-CGRP COMPOSITIONS AND USE THEREOF | Final Rejection | ALDERBIO HOLDINGS LLC |
| 17624121 | RECOMBINANT HUMAN SIALIDASES, SIALIDASE FUSION PROTEINS, AND METHODS OF USING THE SAME | Non-Final OA | Palleon Pharmaceuticals Inc. |
| 18044511 | A METHOD OF EVALUATING SPERM HEALTH AND IDENTIFYING SPERM TO BE USED IN ASSIS REPRODUCTIVE TECHNOLOGIES | Non-Final OA | The Provost, Fellows, Foundation Scholars, & The Other Members of Board, Of The College Of The Holy |
| 18334680 | Glycan-Interacting Compounds and Methods of Use | Non-Final OA | Seagen Inc. |
| 18256599 | ANTIBODY SPECIFICALLY BINDING TO STREP-TAG II TAG AND USE THEREOF | Non-Final OA | BEIJING YIMIAOYILIAO CO., LTD |
| 17926668 | Screening method for effective target - E3 ligase combinations | Non-Final OA | UMC Utrecht Holding B.V. |
| 18002975 | AMH AND/OR INHIBIN B AS A BIOMARKER FOR AN EFFECT OF A TREATMENT TO IMPROVE MALE FERTILITY | Non-Final OA | XY Therapeutics ApS |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy